Katherine L. Lev

645 total citations
19 papers, 366 citations indexed

About

Katherine L. Lev is a scholar working on Ecology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Katherine L. Lev has authored 19 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Ecology, 9 papers in Infectious Diseases and 8 papers in Molecular Medicine. Recurrent topics in Katherine L. Lev's work include Bacteriophages and microbial interactions (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Katherine L. Lev is often cited by papers focused on Bacteriophages and microbial interactions (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Katherine L. Lev collaborates with scholars based in United States, Colombia and Slovenia. Katherine L. Lev's co-authors include Razieh Kebriaei, Michael J. Rybak, Taylor Morrisette, Sandra Morales, Kyle Stamper, Susan M. Lehman, Dana Holger, Jacinda C. Abdul‐Mutakabbir, César A. Arias and Ashlan J. Kunz Coyne and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Journal of Applied Microbiology.

In The Last Decade

Katherine L. Lev

17 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine L. Lev United States 12 248 145 126 103 94 19 366
Thaysa Leite Tagliaferri Brazil 5 219 0.9× 100 0.7× 147 1.2× 28 0.3× 85 0.9× 15 333
Ben Burrowes United States 4 311 1.3× 148 1.0× 151 1.2× 70 0.7× 45 0.5× 14 397
Pengjuan Gong China 9 301 1.2× 162 1.1× 181 1.4× 61 0.6× 33 0.4× 9 421
James Regeimbal United States 7 149 0.6× 83 0.6× 98 0.8× 46 0.4× 87 0.9× 9 316
Bo Youn Moon South Korea 8 134 0.5× 67 0.5× 187 1.5× 130 1.3× 46 0.5× 10 347
Longxiang Xie China 11 177 0.7× 95 0.7× 212 1.7× 59 0.6× 44 0.5× 18 398
Callum Cooper Sweden 11 276 1.1× 126 0.9× 140 1.1× 96 0.9× 24 0.3× 14 387
Kanate Thitiananpakorn Japan 8 104 0.4× 39 0.3× 234 1.9× 94 0.9× 64 0.7× 12 361
Xin-Ee Tan Japan 8 90 0.4× 45 0.3× 129 1.0× 92 0.9× 45 0.5× 12 238
Chythanya Rajanna Das United States 8 308 1.2× 129 0.9× 130 1.0× 78 0.8× 57 0.6× 9 358

Countries citing papers authored by Katherine L. Lev

Since Specialization
Citations

This map shows the geographic impact of Katherine L. Lev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine L. Lev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine L. Lev more than expected).

Fields of papers citing papers by Katherine L. Lev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine L. Lev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine L. Lev. The network helps show where Katherine L. Lev may publish in the future.

Co-authorship network of co-authors of Katherine L. Lev

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine L. Lev. A scholar is included among the top collaborators of Katherine L. Lev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine L. Lev. Katherine L. Lev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pereira, Filipa, et al.. (2024). Optimized production of concanamycins using a rational metabolic engineering strategy. Metabolic Engineering. 88. 63–76.
2.
Kebriaei, Razieh, Jacinda C. Abdul‐Mutakabbir, Kyle Stamper, Katherine L. Lev, & Michael J. Rybak. (2023). Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin. Infectious Diseases and Therapy. 12(10). 2485–2494. 1 indexed citations
3.
Morrisette, Taylor, Kyle Stamper, Katherine L. Lev, et al.. (2023). Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrobial Agents and Chemotherapy. 67(6). e0131722–e0131722. 4 indexed citations
4.
Holger, Dana, Amer El Ghali, Katherine L. Lev, et al.. (2023). Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models. Antimicrobial Agents and Chemotherapy. 67(11). e0057823–e0057823. 18 indexed citations
5.
Kebriaei, Razieh, Katherine L. Lev, Kyle Stamper, et al.. (2022). Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination. Microbiology Spectrum. 10(2). e0041122–e0041122. 31 indexed citations
6.
Lev, Katherine L., Ashlan J. Kunz Coyne, Razieh Kebriaei, et al.. (2022). Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium. Antibiotics. 11(3). 392–392. 18 indexed citations
7.
Holger, Dana, Katherine L. Lev, Razieh Kebriaei, et al.. (2022). Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing. Journal of Applied Microbiology. 133(3). 1636–1649. 30 indexed citations
8.
Kebriaei, Razieh, Kyle Stamper, Katherine L. Lev, et al.. (2021). Exebacase in Addition to Daptomycin against MRSA. Antimicrobial Agents and Chemotherapy. 65(11). e0012821–e0012821. 7 indexed citations
9.
Holger, Dana, Katherine L. Lev, Razieh Kebriaei, et al.. (2021). 132. Evaluation Phage Cocktails in Combination with Ciprofloxacin Against Multidrug-Resistant Pseudomonas aeruginosa Overexpressing MexAB-OprM Efflux Systems. Open Forum Infectious Diseases. 8(Supplement_1). S81–S81.
10.
Holger, Dana, et al.. (2021). Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections. Antibiotics. 10(5). 556–556. 23 indexed citations
11.
Morrisette, Taylor, Katherine L. Lev, Razieh Kebriaei, et al.. (2020). Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities. Antimicrobial Agents and Chemotherapy. 64(9). 32 indexed citations
12.
Abdul‐Mutakabbir, Jacinda C., Kyle Stamper, Katherine L. Lev, et al.. (2020). 1295. Activity of SPR206, a Polymyxin B Derivative, Compared to Colistin Alone and in Combination Against Multidrug-Resistant Pseudomonas aeruginosa Strains. Open Forum Infectious Diseases. 7(Supplement_1). S662–S663. 3 indexed citations
13.
Kebriaei, Razieh, Katherine L. Lev, Kyle Stamper, et al.. (2020). Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 65(1). 21 indexed citations
14.
Kebriaei, Razieh, Katherine L. Lev, Taylor Morrisette, et al.. (2020). Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 64(7). 51 indexed citations
15.
16.
Abdul‐Mutakabbir, Jacinda C., Kyle Stamper, Razieh Kebriaei, et al.. (2020). 1297. In-Vitro Antibacterial Activities of Cefiderocol (S-649266) Alone and With the Addition of Beta-Lactamase Inhibitors Against Multidrug-resistant Acinetobacter baumannii. Open Forum Infectious Diseases. 7(Supplement_1). S663–S663. 1 indexed citations
17.
Yim, Juwon, Razieh Kebriaei, Jordan R. Smith, et al.. (2020). Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model. Antimicrobial Agents and Chemotherapy. 64(5). 24 indexed citations
18.
Morrisette, Taylor, Razieh Kebriaei, Katherine L. Lev, Sandra Morales, & Michael J. Rybak. (2019). Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(2). 153–168. 75 indexed citations
19.
Mady, Ahmed S.A., Chenzhong Liao, Fardokht A. Abulwerdi, et al.. (2018). Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening. Scientific Reports. 8(1). 10210–10210. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thaysa Leite Tagliaferri Breakdown of academic impact, for papers by Ben Burrowes Breakdown of academic impact, for papers by Pengjuan Gong Breakdown of academic impact, for papers by James Regeimbal Breakdown of academic impact, for papers by Bo Youn Moon Breakdown of academic impact, for papers by Longxiang Xie Breakdown of academic impact, for papers by Callum Cooper Breakdown of academic impact, for papers by Kanate Thitiananpakorn Breakdown of academic impact, for papers by Xin-Ee Tan Breakdown of academic impact, for papers by Chythanya Rajanna Das
Rankless by CCL
2026